Advisory Services Network’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Advisory Services Network’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8	Closed	-$859	–	3937
2023 Q1	$859	Buy	8 +2	+33%	+$230	﹤0.01%	3641
2022 Q4	$660	Buy	+6	New	+$389	﹤0.01%	3690

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Advisory Services Network's RXDX Position: Q2 2023 in Review

Advisory Services Network sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 8 shares — an estimated $859 sold.

Advisory Services Network first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $859 in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Advisory Services Network reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Advisory Services Network sold 8 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $859.
Advisory Services Network first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Advisory Services Network's Prometheus Biosciences, Inc. Common Stock position peaked at $859 in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.